Do newly marketed generic medicines expand markets using descriptive time series analysis and mixed logit models? Korea as an exemplar and its implications-Reference-Cited by-同舟云学术

Do newly marketed generic medicines expand markets using descriptive time series analysis and mixed logit models? Korea as an exemplar and its implications

Published:2016-04-14 Issue:1 Volume:16 Page:
ISSN:1472-6963
Container-title:BMC Health Services Research
language:en
Short-container-title:BMC Health Serv Res

Author:

Kwon Hye-Young,Godman Brian

Publisher

Springer Science and Business Media LLC

Subject

Health Policy

Link

http://link.springer.com/content/pdf/10.1186/s12913-016-1356-z

Reference50 articles.

1. Kesselheim AS, Misono AS, Lee JL, Stedman MR, Brookhart MA, Choudhry NK, et al. Clinical equivalence of generic and brand-name drugs used in cardiovascular disease: a systematic review and meta-analysis. JAMA. 2008;300(21):2514–26.

2. Corrao G, Soranna D, Arfe A, Casula M, Tragni E, Merlino L, et al. Are generic and brand-name statins clinically equivalent? Evidence from a real data-base. Eur J Intern Med. 2014;25(8):745–50.

3. Haas JS, Phillips KA, Gerstenberger EP, Seger AC. Potential Savings from Substituting Generic Drugs for Brand-Name. Ann Intern Med. 2005;142(11):891–7.

4. Kanavos P. Do generics offer significant savings to the UK National Health Service? Curr Med Res Opin. 2007;23:105–16.

5. Dylst P, Vulto A, Simoens S. Analysis of European policy towards generic medicines. GaBi J. 2014;3(1):34–5.

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The long-term effect of generic price competition on the Hungarian statin market;BMC Health Services Research;2023-05-06

2. Predicting technological innovation in new energy vehicles based on an improved radial basis function neural network for policy synergy;PLOS ONE;2022-08-25

3. Real-world Evidence for Adherence and Persistence with Atorvastatin Therapy;Cardiology and Therapy;2021-09-29

4. Use of budget savings from patent expiration of cancer drugs to improve affordability and accessibility;BMC Health Services Research;2021-02-06

5. Uptake of Biosimilar Infliximab in the UK, France, Japan, and Korea: Budget Savings or Market Expansion Across Countries?;Frontiers in Pharmacology;2020-07-09